Anand V Kulkarni
anandvkulkarni.bsky.social
Anand V Kulkarni
@anandvkulkarni.bsky.social
Hepatologist at AIG Hospitals, Hyderabad, India. Interests in ALD, ACLF & HCC
Thank you 🙏🏻
March 29, 2025 at 12:54 AM
Yes . No doubt 😞
March 14, 2025 at 2:00 AM
Thank you Hanna. In our settings most patients don’t agree for LT at all & we see at least 4 new AH patients per day and hardly one may fit for steroids therapy up front. We usually stabilize and then start steroids. Under supervision they do pretty well.
March 14, 2025 at 12:58 AM
Thank you Rohit
March 13, 2025 at 5:24 PM
Tips cannot prevent cirrhosis progression. Patients are okay without bleed for 3-4 years- then continue to develop complications. Having said that yes,I strongly recommend TIPS for bleeders but not for refractory ascites.Very poor outcomes! The QoL post TIPS for ascites is significantly affected.
January 5, 2025 at 11:50 AM
Absolutely sir. Patient selection is the key!
December 12, 2024 at 5:36 PM
Hey Vinay, thank you. Nice meeting you.
Best
November 19, 2024 at 9:53 PM
Reposted by Anand V Kulkarni
Dose tapering reduced incidence of infection and use of antibiotics. No difference noted in survival #TLM24 #LiverSky
November 18, 2024 at 11:24 PM
No difference in mortality though.
November 19, 2024 at 3:59 PM